237 related articles for article (PubMed ID: 21082260)
21. Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis.
Zhang ZJ; Hao K; Shi R; Zhao G; Jiang GX; Song Y; Xu X; Ma J
Am J Epidemiol; 2011 Apr; 173(8):847-57. PubMed ID: 21436184
[TBL] [Abstract][Full Text] [Related]
22. Glutathione S-transferase M1 polymorphism and colorectal cancer risk in Chinese population.
Teng Z; Wang L; Zhang J; Cai S; Liu Y
Tumour Biol; 2014 Mar; 35(3):2117-21. PubMed ID: 24197978
[TBL] [Abstract][Full Text] [Related]
23. Glutathione S-transferase M1 gene polymorphism and laryngeal cancer risk: a meta-analysis.
Ying XJ; Dong P; Shen B; Xu CZ; Xu HM; Zhao SW
PLoS One; 2012; 7(8):e42826. PubMed ID: 22900055
[TBL] [Abstract][Full Text] [Related]
24. Association of Glutathione S-Transferase M1 null genotype with inflammatory bowel diseases: A systematic review and meta-analysis.
Zhou YJ; Zhao BL; Qian Z; Xu Y; Ding YQ
Medicine (Baltimore); 2019 Nov; 98(44):e17722. PubMed ID: 31689810
[TBL] [Abstract][Full Text] [Related]
25. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
26. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects.
Zhou HF; Feng X; Zheng BS; Qian J; He W
Mol Biol Rep; 2013 Oct; 40(10):5713-21. PubMed ID: 24072652
[TBL] [Abstract][Full Text] [Related]
28. Glutathione S-transferase M1 gene polymorphism and gastric cancer risk: an updated analysis.
Chen B; Zhou Y; Yang P; Wu XT
Arch Med Res; 2010 Oct; 41(7):558-66. PubMed ID: 21167396
[TBL] [Abstract][Full Text] [Related]
29. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers.
Jong Jeong H; Jin Kim H; Young Seo I; Ju Kim H; Oh GJ; Cheon Chae S; Sik Lim J; Taeg Chung H; Joong Kim J
Cancer Lett; 2003 Dec; 202(2):193-9. PubMed ID: 14643449
[TBL] [Abstract][Full Text] [Related]
30. Combined effects of glutathione S-transferase M1 and T1 polymorphisms on risk of lung cancer: Evidence from a meta-analysis.
Gao Y; Gao F; Hu TT; Li G; Sui YX
Oncotarget; 2017 Apr; 8(17):28135-28143. PubMed ID: 28427236
[TBL] [Abstract][Full Text] [Related]
31. Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies.
Chen B; Cao L; Zhou Y; Yang P; Wan HW; Jia GQ; Liu L; Wu XT
Dig Dis Sci; 2010 Jul; 55(7):1831-8. PubMed ID: 19960261
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis.
Xue H; Su J; Sun K; Xie W; Wang H
Mol Biol Rep; 2012 Apr; 39(4):5033-42. PubMed ID: 22160572
[TBL] [Abstract][Full Text] [Related]
34. Association of GSTM1 null allele with prostate cancer risk: evidence from 36 case-control studies.
Wei B; Xu Z; Zhou Y; Ruan J; Cheng H; Xi B; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z; Xuan F; Huang X; Zhang J; Zhou H
PLoS One; 2012; 7(10):e46982. PubMed ID: 23071687
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
[TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase T1 polymorphism contributes to bladder cancer risk: a meta-analysis involving 50 studies.
Gong M; Dong W; An R
DNA Cell Biol; 2012 Jul; 31(7):1187-97. PubMed ID: 22339266
[TBL] [Abstract][Full Text] [Related]
37. Glutathione S-transferase P1 gene polymorphism associated with gastric cancer among Caucasians.
Zhou Y; Li N; Zhuang W; Yin YQ; Liu GJ; Wu TX; Yao X; Du L; Wei ML; Wu XT
Eur J Cancer; 2009 May; 45(8):1438-42. PubMed ID: 19157859
[TBL] [Abstract][Full Text] [Related]
38. Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies.
Lu QJ; Bo YC; Zhao Y; Zhao EJ; Sapa WB; Yao MJ; Duan DD; Zhu YW; Lu WQ; Yuan L
World J Gastroenterol; 2016 Feb; 22(5):1911-8. PubMed ID: 26855551
[TBL] [Abstract][Full Text] [Related]
39. [Glutathione S-transferase M1 polymorphism and susceptibility to breast cancer in Chinese population: a meta-analysis].
Wan G; Li F; Li W; Sun J; Cao Y
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):158-62. PubMed ID: 24842013
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
